European Vaccine Initiative

EVI was formally established as a European Economic Interest Grouping (EEIG) by a set of statutes signed in August 2009 between the founding Universities of Stockholm and Heidelberg.  In 2010 the EEIG was augmented by the following four prominent institutions: the Biomedical Primate Research Centre, Rijswijk, the Jenner Vaccine Foundation, Oxford, the Netherlands Vaccine Institute, Bilthoven, and the Royal College of Surgeons in Ireland, Dublin.

EVI’s mission is to contribute to the global efforts to control diseases of poverty by creating an environment conducive to accelerating the development and clinical assessment of vaccine candidates for diseases of poverty, promoting the affordability and accessibility of vaccines for diseases of poverty in low-income populations, aligning all major stakeholders and acting as a focal point to ensure the successful development of vaccines for diseases of poverty for low-income populations, and communicating to stakeholders and public the importance of EVI's work and progress towards the deployment of affordable and efficacious vaccine candidates for diseases of poverty.

For more information, please vist www.euvaccine.eu.